JP2021063088A5
(cg-RX-API-DMAC7.html )
2021-10-28
JP2024540183A5
(cg-RX-API-DMAC7.html )
2026-03-19
MX2023000798A
(es )
2023-02-27
Peptidos funcionalizados como agentes antivirales.
MX2023005984A
(es )
2023-08-17
Nuevos agentes antivirales derivados de la espiropirrolidina.
JP2023002662A5
(cg-RX-API-DMAC7.html )
2023-02-17
JP2010532373A5
(cg-RX-API-DMAC7.html )
2011-07-21
JP2010532372A5
(cg-RX-API-DMAC7.html )
2011-07-28
JP2015528471A5
(cg-RX-API-DMAC7.html )
2016-10-20
JP2017531038A5
(cg-RX-API-DMAC7.html )
2018-11-22
JP2020507589A5
(cg-RX-API-DMAC7.html )
2021-03-11
IL314873A
(en )
2024-10-01
Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
JP2015508749A5
(cg-RX-API-DMAC7.html )
2015-06-18
PH12021552930A1
(en )
2022-04-04
1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
JP2008521827A5
(cg-RX-API-DMAC7.html )
2009-02-05
JP2020512337A5
(cg-RX-API-DMAC7.html )
2020-06-11
JP2019517587A5
(cg-RX-API-DMAC7.html )
2020-07-30
JP2016514141A5
(cg-RX-API-DMAC7.html )
2017-04-13
JP2010527985A5
(cg-RX-API-DMAC7.html )
2011-06-30
JP2019533660A5
(cg-RX-API-DMAC7.html )
2020-10-22
JPWO2023195530A5
(cg-RX-API-DMAC7.html )
2025-01-14
JP2024531188A5
(cg-RX-API-DMAC7.html )
2025-10-15
JPWO2023054732A5
(cg-RX-API-DMAC7.html )
2023-09-06
JP2013506004A5
(cg-RX-API-DMAC7.html )
2013-10-17
JP2024544538A5
(cg-RX-API-DMAC7.html )
2025-11-18
JP2022551691A5
(cg-RX-API-DMAC7.html )
2023-10-17